S-Space College of Medicine/School of Medicine (의과대학/대학원) Program in Cancer Biology (협동과정-종양생물학전공) Theses (Master's Degree_협동과정-종양생물학전공)
Autophagy and PERK-eIF2α pathway protect ovarian cancer cells from metformin-induced apoptosis : 난소암 세포주에서 Metformin에 의한 자가포식작용과 미접힘 단백질 반응의 기전 연구
Cited 0 time in Web of Science Cited 0 time in Scopus
- 의과대학 협동과정 종양생물학전공
- Issue Date
- 서울대학교 대학원
- Ovarian cancer cells ; Metformin ; Apoptosis ; Autophagy ; PERK
- 학위논문 (석사)-- 서울대학교 대학원 : 협동과정 종양생물학전공, 2014. 8. 송용상.
- Metformin, an oral biguanide for the treatment of type II diabetes, has been shown to have anticancer effect in ovarian cancer. Metformin induces starvation, causing endoplasmic reticulum (ER) stress and autophagy. The unfolded protein response (UPR) signaling by ER stress and autophagy acted as a survival or a death mechanism depending on types of malignancies. In this study, we found that metformin-induced apoptosis was relieved by autophagy and PERK/eIF2α pathway selectively in ovarian cancer cells, but not in normal cells, such as normal ovarian surface epithelial cells (OSE) and peripheral blood mononuclear cells (PBMC). Metformin induced autophagy, was verified by molecular markers, LC3B and ATG12-ATG5 for autophagosome formation at an early stage, and p62 along with increase of acidic vacuoles stained by acridine orange to detect degradation of the autophagosome at a late stage. Interestingly, metformin induced interdependent activation of autophagy and unfolded protein response (UPR), especially PERK/eIF2α pathway. Interaction of autophagy with PERK/eIF2α pathway played a protective role in ovarian cancer cells against metformin-induced apoptosis, demonstrated by assay using small molecular inhibitors. Finally, metformin with pharmacologic inhibitors had no effects on OSE and PBMC. In conclusion, these results suggest that inhibition of interaction between autophagy and PERK could enhance selective anticancer effect of metformin in ovarian cancer cells.
- Files in This Item:
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.